HB593 creates a new regulatory framework in Missouri for cannabinoid products, with a particular focus on intoxicating cannabinoids and hemp-derived consumable beverage products. The bill defines key terms such as hemp, marijuana, intoxicating cannabinoid, hemp-derived cannabinoid, and hemp-derived consumable beverage product, and it draws a distinction between nonintoxicating hemp products and products that contain intoxicating cannabinoids. Under the bill, intoxicating cannabinoid products are treated as marijuana and would be regulated by the Department of Health and Senior Services in the same manner as marijuana under Article XIV of the Missouri Constitution.
The bill also establishes a separate licensing, testing, labeling, registration, and enforcement system for hemp-derived consumable beverage products. It requires manufacturers, distributors, retailers, and certain food service or on-premises retail establishments to obtain licenses, comply with product registration and certificate-of-analysis requirements, and follow detailed packaging and warning-label rules. The bill sets age restrictions at 21 and older, prohibits sales to minors, restricts marketing that appeals to children, limits direct shipment to Missouri residents, and authorizes inspections, seizures, and forfeiture for violations. It also creates the Hemp Business Fund to support administration of the program and imposes a 2% excise tax on retail sales of hemp-derived consumable beverage products beginning in 2026.
HB593 would significantly affect chapters 144 and 195, RSMo, by adding new sections that regulate cannabinoid commerce and taxation. It would also interact with Missouri’s marijuana laws and constitutional framework by classifying intoxicating cannabinoids as marijuana while expressly excluding hemp, industrial hemp, and hemp-derived consumable beverage products that do not contain intoxicating cannabinoids from marijuana regulation. The bill further directs the department to promulgate rules, coordinate with law enforcement, and enforce the new standards, while preserving interstate hemp commerce and avoiding conflict with federal hemp law.
The general sentiment reflected in the bill text is regulatory and permissive rather than prohibitive: it appears designed to legalize and structure a market for hemp-derived beverage products while tightening controls around intoxicating cannabinoid products. Because there were no committee transcripts or recorded votes provided, there is no documented floor or committee sentiment to summarize beyond the bill’s detailed compliance-oriented approach. The overall tone of the legislation suggests an effort to bring clarity, consumer protections, and tax revenue to a rapidly developing cannabinoid market.
The main points of contention likely center on how broadly the bill defines “intoxicating cannabinoid,” whether products such as delta-8 THC and THCA should be treated as marijuana, and whether the licensing and labeling regime is too restrictive for hemp businesses. Other likely concerns include the 21-and-over sales limit, the prohibition on direct-to-consumer shipment, the ban on using “dispensary” in business names, and the extent of state authority over products that may already be marketed under federal hemp law. The bill also creates a potential conflict between hemp industry stakeholders seeking broader market access and marijuana regulators or public health advocates favoring tighter controls and enforcement.
HB593 would add a comprehensive new regulatory and tax structure to Missouri law for hemp-derived consumable beverage products and intoxicating cannabinoids. It creates new sections in chapters 144 and 195, establishes licensing and registration requirements, imposes labeling and testing standards, authorizes inspections and enforcement, creates a dedicated Hemp Business Fund, and levies a 2% excise tax on retail sales of hemp-derived consumable beverage products beginning January 1, 2026. It also amends the state’s treatment of cannabinoids by classifying intoxicating cannabinoids as marijuana for regulatory purposes while excluding nonintoxicating hemp products and hemp-derived consumable beverage products from marijuana regulation.
The bill’s overall tone is regulatory but supportive of a legal hemp beverage market. It appears intended to create a controlled pathway for sale of hemp-derived consumable beverage products while also addressing public health, youth access, and impaired-driving concerns. Because no committee discussion or votes were provided, there is no recorded legislative debate to indicate support or opposition beyond the structure of the bill itself.
Likely areas of dispute include the bill’s broad definition of intoxicating cannabinoids, its treatment of products like delta-8 THC and THCA as marijuana, and the extent to which the state should regulate hemp-derived beverages under marijuana-style rules. Industry stakeholders may object to licensing fees, registration, testing, shipment restrictions, and the ban on using “dispensary” in business names, while public health or law enforcement interests may support the age limits, labeling rules, and enforcement provisions. The tax provision and the requirement that intoxicating cannabinoid products be sold only through licensed marijuana facilities may also be contentious.